InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Murthy Mala, 首席财务官. Officer active across 3 companies, notably Teladoc Health, Inc.. Aggregated, 26 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €182k. History available since 28 October 2021. The latest transaction was filed on 15 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Murthy Mala
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报26 总计
1,166 股@ US$68.75Common StockSEC:0001780955-26-000006:0
46,260 股0Common StockSEC:0001780955-26-000002:0
8,319 股0Common StockSEC:0001780955-25-000006:0
2,641 股Common StockSEC:0001477449-25-000105:0
2,641 股Common StockSEC:0001477449-25-000081:0
17,100 股0Common StockSEC:0001722482-25-000150:0
12,652 股Common StockSEC:0001477449-25-000044:0
36,933 股Common StockSEC:0001477449-25-000035:0
3,369 股Common StockSEC:0001477449-25-000020:0
2,641 股Common StockSEC:0001628280-24-049797:0
2,641 股Common StockSEC:0001477449-24-000193:0
2,641 股Common StockSEC:0001477449-24-000155:0
8,477 股0Common StockSEC:0001722482-24-000117:0
10,565 股Common StockSEC:0001477449-24-000039:0
3,369 股Common StockSEC:0001477449-23-000106:0
3,369 股Common StockSEC:0001477449-23-000040:0
3,368 股Common StockSEC:0001415889-23-009199:0
9,808 股0Common StockSEC:0001722482-23-000119:0
7,438 股@ US$25.911100.0% 占其流量Common StockSEC:0001415889-23-004411:0
13,475 股Common StockSEC:0001415889-23-004087:0
7,968 股Common StockSEC:0001415889-22-007017:0
6,693 股0Common StockSEC:0001722482-22-000128:0
1,215 股0Common StockSEC:0001722482-22-000083:0
2,677 股Common StockSEC:0001415889-22-002576:0
916 股0Common StockSEC:0001722482-21-000250:0
26 条申报中的 25 条
About Murthy Mala
Murthy Mala is Directeur Financier. Across 25 filings in total, the 25 sampled filings cover the period from 2021-06-28 to 2026-03-24 and show 0 in purchases and 181822 in sales, with Levée d'options as the modal transaction nature. The companies mentioned in these filings are Teladoc Health, Inc., Avantor, Inc. and Trinet Group, INC.
